Clinical Trial Update: FASTMAS (Fast-Fail Trials in Mood and Anxiety Spectrum Disorders) Kappa Opioid Receptor Phase 1 Study [Phase 1]

View source ↗

Summary

FASTMAS (Fast-Fail Trials in Mood and Anxiety Spectrum Disorders) Kappa Opioid Receptor Phase 1 Study for anxiety disorders has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders

Snippet

Sponsor: Andrew Krystal | Conditions: Anxiety Disorders | Phase 1 | Status: WITHDRAWN